Proven Safe. Proven Effective.

Used in clinical trials for 1,074 newborns, the Dream Warmer treated or prevented hypothermia in 92% of cases—with no safety concerns reported.

Across three clinical trials in Rwanda, the Dream Warmer consistently prevented or treated neonatal hypothermia, with high success rates and no reported safety concerns in over 1,000 uses.

The Dream Warmer has delivered safe and effective warmth to newborns in additional implementation studies worldwide, with overwhelmingly positive feedback from both healthcare providers and parents.

Implementation Science Studies

Mexico — Implementation Study

In this implementation science study conducted in Chiapas, Mexico, the use of the Dream Warmer™ was associated with a significant reduction in neonatal hypothermia. Hypothermia rates on admission decreased from 62% to 27%, and from 59% to 11% at follow-up. Mean admission and follow-up temperatures increased by 0.06°C and 0.23°C, respectively. Healthcare providers’ knowledge of hypothermia and confidence in keeping newborns warm also improved throughout the study.

📄 Prevention and Treatment of Neonatal Hypothermia in Chiapas, Mexico

Malawi — Real-World Use Study

In this implementation science study, the Dream Warmer performed well, effectively treating hypothermia in 90% of uses, and with a positive reception by health care providers and parents.

📄 Introduction of a Novel Neonatal Warming Device in Malawi

Rwanda — Implementation Science Study

In this mixed methods implementation science study of the Dream Warmer™ across 6 district hospitals and 84 associated health centers in rural Rwanda, the mean admission temperature rose from slightly hypothermic (36.41 °C), to euthermic (36.53 °C) when the Warmer was introduced. Infants’ hypothermia was treated effectively in 86% of uses. It raised no safety concerns and was used correctly in the vast majority of cases. Health care providers and parents reported a generally positive experience with the Warmer.

📄 An Implementation Study of a Heat-Producing Wrap to Complement KMC

Clinical Trials

Rwanda — Stepped-Wedge Trial

In this cluster randomized stepped wedge trial across 10 district hospitals in rural Rwanda, the rate of normal temperature across all infants rose from 51% to 67%; of infants who used the warmer, only 11% remained hypothermic, and the mortality rate fell by 67% to 0.9% compared to 2.8% for those who never used the Warmer.

📄Safety and Effectiveness of a Non-Electric Infant Warmer in Rwanda

Rwanda — Pilot Study

lIn this mixed methods pilot study of the Dream Warmer™, 99% of infants who remained on the Warmer for at least one hour achieved euthermia with no safety concerns or instances of incorrect use, and overall positive reception by health care providers.

Performance of a Nonelectric Infant Warmer in Rwandan Health Centers

Rwanda — Prototype Evaluation

In this pilot study of a research prototype of the Dream Warmer conducted in a rural site in Rwanda, 95% of hypothermic babies became warm and 100% of babies for whom skin to skin care was unavailable stayed warm with no safety concerns or incorrect uses.

📄 A Low-Cost, Reusable Infant Warmer: Early Feasibility and Safety Study